[R9S-R14S-R17S]cTI

General Information


DRACP ID  DRACP00922

Peptide Name   [R9S-R14S-R17S]cTI

Sequence  KWCFRVCYSGICYSRCSG

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  host defense peptide from the horseshoe crab Tachypleus tridentatus

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
K562 Blast phase chronic myelogenous leukemia, BCR-ABL1 positive; Chronic myeloid leukemia Leukemia CC50=4.8±0.3 µM Resazurin assay 24h 1
HT-144 Melanoma Carcinoma CC50=11.8±0.9 µM Resazurin assay 24h 1
WM164 Cutaneous melanoma Carcinoma CC50=11.1±0.9 µM Resazurin assay 24h 1

Hemolytic Activity  Human RBCs: CC50=15.3±1.4 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antitumor



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00922

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys3<--->Cys16; Cys7<--->Cys12

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C92H136N26O24S4

Absent amino acids  ADEHLMNPQT

Common amino acids  C

Mass  242189

Pl  8.67

Basic residues  3

Acidic residues  0

Hydrophobic residues  4

Net charge  3

Boman Index  -2460

Hydrophobicity  10.56

Aliphatic Index  37.78

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  8730

Absorbance 280nm  513.53

Polar residues  11

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31714739

Title  Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties

Doi 10.1021/acschembio.9b00782

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.